1036991-50-0

Basic information

• Product Name: 1-(imidazo[1,2-a]pyridin-7-yl)ethanone
• Synonyms: 1-(imidazo[1,2-a]pyridin-7-yl)ethanone
• CAS NO: 1036991-50-0
• Molecular Formula: C₉H₈N₂O
• Molecular Weight: 160.17262
• Mol File: 1036991-50-0.mol

Chemical Properties

• Appearance: /
• Density: 1.21±0.1 g/cm3(Predicted)
• PKA: 4.46±0.50(Predicted)
• CAS DataBase Reference: 1-(imidazo[1,2-a]pyridin-7-yl)ethanone(CAS DataBase Reference)
• NIST Chemistry Reference: 1-(imidazo[1,2-a]pyridin-7-yl)ethanone(1036991-50-0)
• EPA Substance Registry System: 1-(imidazo[1,2-a]pyridin-7-yl)ethanone(1036991-50-0)

Safety Data

• Hazardous Substances Data: 1036991-50-0(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
1-(imidazo[1,2-a]pyridin-7-yl)ethanone is used as a pharmaceutical intermediate for the synthesis of various drug molecules. Its unique structure and potential biological activity make it a valuable compound in the development of new medications.
Used in Organic Synthesis:
In the field of organic synthesis, 1-(imidazo[1,2-a]pyridin-7-yl)ethanone serves as a key building block for the creation of more complex organic molecules. Its reactivity and functional groups allow for various chemical reactions, enabling the synthesis of a wide range of compounds.
Used in Material Development:
1-(imidazo[1,2-a]pyridin-7-yl)ethanone is utilized in the development of new materials due to its unique chemical properties. Its potential applications in material science include the creation of advanced polymers, coatings, and other innovative materials with specific properties.
Used in Medicinal Chemistry Research:
As a compound with potential biological activity, 1-(imidazo[1,2-a]pyridin-7-yl)ethanone is employed in medicinal chemistry research to explore its interactions with biological systems. This research aims to understand its potential therapeutic effects and mechanisms of action, which could lead to the discovery of new drugs and treatments.

Upstream product

• 342613-80-3 7-hydroxymethylimidazo[1,2-a]pyridine 
• 136117-73-2 7-imidazo<1,2-a>pyridinecarboxaldehyde 
• 1251900-00-1 1-(imidazol[1,2-a]pyridin-7-yl)ethan-1-ol 
• 808744-34-5 7-bromoimidazo[1,2-a]pyridine 
• 97674-02-7 tributyl(1-ethoxyvinyl)stannane 
• 84249-14-9 2-amino-4-bromopyridine 

Downstream Products

• 1141505-08-9 1-[3-(7-acetyl-imidazo[1,2-a]pyridin-3-yl)-phenyl]-3-(2,2,2-trifluoro-ethyl)-urea 
• 1316087-80-5 1-[3-(7-{1-Hydroxyimino-ethyl}-imidazo[1,2-a]pyridin-3-yl)-phenyl]-3-(2,2,2-trifluoro-ethyl)-urea 
• 1251899-88-3 1-[3-(7-{(E)-1-2-hydroxyethoxyiminoethyl}imidazo[1,2-a]pyridin-3-yl)phenyl]-3-(2,2,2-trifluoroethyl)urea 
• 882187-80-6 2-imidazo[1,2-a]pyridin-7-ylpropan-2-ol 

Relevant articles and documents

GLYCOSIDASE INHIBITORS

Compounds of formula (I) wherein A, R, W, Q, n and m have the meaning according to the claims can be employed, inter alia, for the treatment of tauopathies and Alzheimer's disease.

GLYCOSIDASE INHIBITORS

Compounds of formula (I) wherein A, R, W, Q, n and m have the meaning according to the claims can be employed, inter alia, for the treatment of tauopathies and Alzheimer's disease.

COMPOUNDS FOR TREATING SPINAL MUSCULAR ATROPHY

Provided herein are compounds, compositions thereof and uses therewith for treating spinal muscular atrophy.

BICYCLIC HETEROCYCLYL DERIVATIVES AS FGFR KINASE INHIBITORS FOR THERAPEUTIC USE

The invention relates to new bicyclic heterocyclyl derivatives of formula (I), to pharmaceutical compositions comprising said compounds and to the use of said compounds in the treatment of diseases, e.g. cancer.